B
Bull
Bull · 25%PRTG
$6.64
Precio del escenario
$6.810
-0.147 (-2.16%)Al cierre
Loading chart…
- High
- 9.430
- Open
- 7.600
- VWAP
- 7.68
- Vol
- 388.29K
- Mkt Cap
- 4.47M
- Low
- 6.801
- Amount
- 2.98M
- EV/EBITDA, TTM
- 0.00
AlphaTON Capital Corp., formerly Portage Biotech Inc., is a specialized digital asset treasury company. The Company is focused on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The Company implements a treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, the Company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. It is also advancing therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The Company engages in the drug development process and provides strategic counsel to guide development of immunotherapy assets and asset combinations.
Métricas de valoración
The current forward P/E ratio for Portage Biotech Inc (PRTG) is -0.57, compared to its 5-year average forward P/E of -3.92.
Alphio AI Price Scenarios for PRTG
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Cronología de eventos
Noticias
8.509-03NewsfilterAlphaTON Capital Corp Introduces TON Digital Asset Treasury Strategy for the Telegram Ecosystem
9.507-25Yahoo FinancePortage Biotech Reports Results for Fiscal Year Ended March 31, 2025
9.506-26BenzingaWhy Worthington Steel Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
7.006-25NASDAQ.COMPortage Biotech Regains Nasdaq Compliance, Maintains Listing On Capital Market
- 7.006-25Newsfilter
Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements
PRTG FAQ — answered by Alphio AI
AlphaTON Capital Corp., formerly Portage Biotech Inc., is a specialized digital asset treasury company. The Company is focused on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The Company implements a treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, the Company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. It is also advancing therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The Company engages in the drug development process and provides strategic counsel to guide development of immunotherapy assets and asset combinations. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.